Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Eriksson

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Alcoholism, Clinical and Experimental Research|May 29, 2004
Effect of moderate alcohol consumption on plasma dehydroepiandrosterone sulfate, testosterone, and estradiol levels in middle-aged men and postmenopausal women: a diet-controlled intervention studyAafje Sierksma, Taisto Sarkola, C J Peter Eriksson, et al.
European Journal of Heart Failure|February 20, 2018
Cognitive performance in late adolescence and long-term risk of early heart failure in Swedish menMartin Lindgren, Peter Eriksson, Annika Rosengren, et al.
Alcoholism, Clinical and Experimental Research|September 25, 2003
Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populationsJohn P Spence, Tiebing Liang, C J Peter Eriksson, et al.
American Heart Journal|May 16, 2016
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)David Erlinge, Sasha Koul, Peter Eriksson, et al.
Nanotoxicology|September 1, 2021
Protein interaction, monocyte toxicity and immunogenic properties of cerium oxide crystals with 5% or 14% gadolinium, cobalt oxide and iron oxide nanoparticles - an interdisciplinary approachMaria Assenhöj, Peter Eriksson, Pierre Dönnes, et al.
Gastroenterology|April 9, 2008
Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injuryJutta Lamlé, Silke Marhenke, Jürgen Borlak, et al.
Genetics|January 14, 2003
Defects in SPT16 or POB3 (yFACT) in Saccharomyces cerevisiae cause dependence on the Hir/Hpc pathway: polymerase passage may degrade chromatin structureTim Formosa, Susan Ruone, Melissa D Adams, et al.
Scientific Reports|May 5, 2018
Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancementPeter Eriksson, Alexey A Tal, Andreas Skallberg, et al.
Alcoholism, Clinical and Experimental Research|September 13, 2005
Is ethanol a pro-drug? Acetaldehyde contribution to brain ethanol effectsEtienne Quertemont, C J Peter Eriksson, Sergey M Zimatkin, et al.
ACS Omega|June 27, 2022
Cerium Oxide Nanoparticles with Entrapped Gadolinium for High <i>T</i> <sub>1</sub> Relaxivity and ROS-Scavenging PurposesPeter Eriksson, Anh H T Truong, Caroline Brommesson, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Alcoholism, Clinical and Experimental Research|May 29, 2004
Effect of moderate alcohol consumption on plasma dehydroepiandrosterone sulfate, testosterone, and estradiol levels in middle-aged men and postmenopausal women: a diet-controlled intervention studyAafje Sierksma, Taisto Sarkola, C J Peter Eriksson, et al.
European Journal of Heart Failure|February 20, 2018
Cognitive performance in late adolescence and long-term risk of early heart failure in Swedish menMartin Lindgren, Peter Eriksson, Annika Rosengren, et al.
Alcoholism, Clinical and Experimental Research|September 25, 2003
Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populationsJohn P Spence, Tiebing Liang, C J Peter Eriksson, et al.
American Heart Journal|May 16, 2016
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)David Erlinge, Sasha Koul, Peter Eriksson, et al.
Nanotoxicology|September 1, 2021
Protein interaction, monocyte toxicity and immunogenic properties of cerium oxide crystals with 5% or 14% gadolinium, cobalt oxide and iron oxide nanoparticles - an interdisciplinary approachMaria Assenhöj, Peter Eriksson, Pierre Dönnes, et al.
Gastroenterology|April 9, 2008
Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injuryJutta Lamlé, Silke Marhenke, Jürgen Borlak, et al.
Genetics|January 14, 2003
Defects in SPT16 or POB3 (yFACT) in Saccharomyces cerevisiae cause dependence on the Hir/Hpc pathway: polymerase passage may degrade chromatin structureTim Formosa, Susan Ruone, Melissa D Adams, et al.
Scientific Reports|May 5, 2018
Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancementPeter Eriksson, Alexey A Tal, Andreas Skallberg, et al.
Alcoholism, Clinical and Experimental Research|September 13, 2005
Is ethanol a pro-drug? Acetaldehyde contribution to brain ethanol effectsEtienne Quertemont, C J Peter Eriksson, Sergey M Zimatkin, et al.
ACS Omega|June 27, 2022
Cerium Oxide Nanoparticles with Entrapped Gadolinium for High <i>T</i> <sub>1</sub> Relaxivity and ROS-Scavenging PurposesPeter Eriksson, Anh H T Truong, Caroline Brommesson, et al.
Pageof 15